Averna Therapeutics a biotechnology company developing genomic medicines that insert therapeutic changes into the genome, announced the appointment of Thomas M. Barnes, Ph.D., as...
HuidaGene Therapeutics, a global clinical-stage biotechnology company focused on advancing CRISPR-based genomic medicines, and Synthego Corporation, a leading provider of innovative CRISPR solutions for...
